Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹2,017 Cr
Revenue (TTM)
₹452 Cr
Net Profit (TTM)
₹51 Cr
ROE
15.5 %
ROCE
21.5 %
P/E Ratio
39.7
P/B Ratio
6.2
Industry P/E
38.59
EV/EBITDA
25.5
Div. Yield
0.7 %
Debt to Equity
0
Book Value
₹113
EPS
₹17.6
Face value
1
Shares outstanding
28,910,630
CFO
₹296.90 Cr
EBITDA
₹415.38 Cr
Net Profit
₹340.11 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amrutanjan Health
| -3.8 | -1.4 | 17.9 | -7.6 | -5.2 | 12.4 | 13.1 |
|
BSE Healthcare
| -2.6 | 5.8 | 11.7 | 19.7 | 25.9 | 22.2 | 11.0 |
|
BSE Small Cap
| -2.6 | 9.6 | 21.0 | 6.2 | 27.3 | 35.1 | 17.6 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Amrutanjan Health
| 17.2 | -15.6 | -24.1 | 86.3 | 16.1 | 54.2 | -9.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amrutanjan Health
|
695.5 | 2,016.8 | 451.8 | 50.8 | 11.4 | 16.3 | 39.7 | 6.2 |
| 475.9 | 7,752.2 | 2,108.1 | 266.8 | 12.5 | 11.7 | 29.1 | 3.4 | |
| 370.7 | 3,729.3 | 819.8 | 69.7 | 13.9 | 11.9 | 53.5 | 6.2 | |
| 451.0 | 2,767.3 | 559.1 | -8.7 | -10.9 | -159 | -- | 3.3 | |
| 5,831.0 | 9,692.5 | 1,218.1 | 251.2 | 28.1 | -- | 38.6 | 18.1 | |
| 985.8 | 9,643.7 | 1,286.4 | 79.6 | 15.9 | 4.7 | 123.2 | 4.1 | |
| 882.5 | 8,141.7 | 4,632.7 | 358.2 | 14.8 | 15 | 2.3 | 3.2 | |
| 689.6 | 5,552.1 | 696.5 | 188.0 | 34.5 | 19.8 | 29.5 | 5.6 | |
| 21.5 | 2,021.0 | 466.0 | 49.4 | 10.7 | 15.1 | 40.9 | 5.9 | |
| 932.6 | 1,950.1 | 759.9 | 61.0 | 8.7 | 12.5 | 32 | 3.9 |
Is your company's RoCE rising every year?
1 min read•By Vikas Vardhan
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms... and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, the Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India. Read more
Incorporated
1936
Chairman
S Sambhu Prasad
Managing Director
S Sambhu Prasad
Group
Amrutanjan
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about Amrutanjan Health Care Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Amrutanjan Health Care Ltd stood at ₹ 421 Cr as on 31-Mar-25
The share price of Amrutanjan Health Care Ltd is ₹695.45 (NSE) and ₹697.60 (BSE) as of 13-Jun-2025 IST. Amrutanjan Health Care Ltd has given a return of -5.21% in the last 3 years.
Amrutanjan Health Care Ltd has a market capitalisation of ₹ 2,017 Cr as on 13-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Amrutanjan Health Care Ltd is 6.17 times as on 13-Jun-2025, a 11% premium to its peers’ median range of 5.57 times.
The P/E ratio of Amrutanjan Health Care Ltd is 39.67 times as on 13-Jun-2025, a 3% premium to its peers’ median range of 38.59 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Amrutanjan Health Care Ltd and enter the required number of quantities and click on buy to purchase the shares of Amrutanjan Health Care Ltd.
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, the Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
The prominent promoters of Amrutanjan Health Care Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
GOODHEALTH HOLDINGS PRIVATE LIMITED |
20.15%
|
|
SAMBHUPRASAD SIVALENKA |
10.34%
|
|
RAMAA PRABHAKAR ARIKIREVULA |
4.74%
|
|
SAMBHU PRASAD SIVALENKA |
3.6%
|
The chairman of the company is S Sambhu Prasad, and the managing director is S Sambhu Prasad.
There is no promoter pledging in Amrutanjan Health Care Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,692
|
|
|
9,644
|
|
|
8,142
|
|
|
7,752
|
|
|
5,552
|
|
|
3,729
|
|
|
2,767
|
|
|
2,021
|
|
|
1,950
|
| Amrutanjan Health Care Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
16.28
|
|
Operating margin(%)
|
11.44
|
|
Net Margin(%)
|
10.83
|
|
Dividend yield(%)
|
0.66
|
Yes, TTM profit after tax of Amrutanjan Health Care Ltd was ₹51 Cr.
₹-5.10
(
